...
首页> 外文期刊>Oncoimmunology. >Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediatedhematopoietic stem cell toxicity.
【24h】

Limitations for TCR gene therapy by MHC-restricted fratricide and TCR-mediatedhematopoietic stem cell toxicity.

机译:MHC限制杀虫剂和TCR介导的造血干细胞毒性对TCR基因治疗的局限性。

获取原文
获取原文并翻译 | 示例
           

摘要

The clinical use of lymphocytes engineered to express high affinity T-cellreceptors (TCRs) specific for two broadly expressed tumor-associated antigens is strongly limited by MHC-restricted fratricide of lymphocytes and TCR-mediatedkilling of hematopoietic stem cells. Specific clinical applications musttherefore be conceived to bypass these limitations.
机译:经过工程改造以表达对两种广泛表达的肿瘤相关抗原具有特异性的高亲和力T细胞受体(TCR)的淋巴细胞的临床应用受到MHC限制性淋巴细胞杀伤剂和TCR介导的造血干细胞杀伤力的强烈限制。因此,必须考虑特定的临床应用来绕开这些限制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号